Showing items 1 - 7 of 7

Barriers and opportunities for the clinical implementation of therapeutic drug monitoring in oncology

- Menz, Bradley D., Stocker, Sophie L., Verougstraete, Nick, Kocic, Danijela, Galettis, Peter, Stove, Christophe P., Reuter, Stephanie E.

Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapy

- Sandaradura, Indy, Marriott, Deborah J. E., Day, Richard O., Norris, Ross L. G., Pang, Edna, Stocker, Sophie L., Reuter, Stephanie E.

Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer

- Teng, Christina, Reuter, Stephanie E., Blinman, Prunella L., Dhillon, Haryana M., Galettis, Peter, Proschogo, Nicholas, McLachlan, Andrew J., Vardy, Janette L.

Inability of current dosing to achieve carboplatin therapeutic targets in people with advanced non-small cell lung cancer: impact of systemic inflammation on carboplatin exposure and clinical outcomes

- Harris, Benjamin D. W., Phan, Viet, Perera, Vidya, Szyc, Anneliese, Galettis, Peter, Martin, Jennifer H., Walpole, Euan, McLachlan, Andrew J., Clarke, Stephen J., Reuter, Stephanie E., Charles, Kellie A.

Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens

- Milliken, Eliza, De Zwart, Auke E. S., Alffenaar, Jan-Willem C., Marriott, Deborah J. E., Riezebos-Brilman, Annelies, Schteinman, Ana, Evans, Allan M., Glanville, Allan R., Verschuuren, Erik A. M., Reuter, Stephanie E.

How 'optimal' are optimal sampling times for tyrosine kinase inhibitors in cancer? Practical considerations

- Ward, Michael B., Reuter, Stephanie E., Martin, Jennifer H.

Pharmacokinetics of cannabis in cancer cachexia-anorexia syndrome

- Reuter, Stephanie E., Martin, Jennifer H.

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit